×

White House Government Agencies

  • TORONTO, Sept 19- Canada's main stock index rose on Monday, led by financials and resource stocks as commodity prices climbed and investors bet that the Federal Reserve would hold U.S. interest rates steady later this week. The loss of momentum for the index is due to uncertainty around what the Fed will do and recent weakness in commodity prices, said Bryden Teich,...

  • NEW YORK, Sept 19- The U.S. dollar weakened on Monday on expectations the Federal Reserve will leave interest rates unchanged after its policymakers meet this week, while oil prices rose from multi-week lows. Weak recent U.S. data has boosted bets that the Fed will skip the chance to raise rates at this week's meeting, but investors will listen closely to Chair...

  • Sept 19- Bowing to pressure from patient advocates, the U.S. Food and Drug Administration on Monday approved a treatment for Duchenne muscular dystrophy even though an outside panel of experts and the agency's own reviewers questioned the drug's efficacy. The FDA's lead reviewer, Dr. In an email to staff on Monday, Woodcock said the approval "reflects FDA's...

  • *Sarepta soars after FDA approves muscle drug. Sept 19- A see-saw session on Wall Street on Monday ended little changed, with gains in big bank stocks offsetting a drag from Apple, as investors braced for the Federal Reserve meeting later this week. The Fed is expected to leave interest rates unchanged at the two-day meeting, but investors will assess Chair Janet...

  • NEW YORK, Sept 19- The Federal Reserve will not raise interest rates when it meets this week, but the U.S. central bank will include "hawkish no-hike language," Jeffrey Gundlach, chief executive of DoubleLine Capital, said on Monday. Currently WIRP, which measures the implied probability of an interest rate hike between 0 and 100, sits around 18 percent for the Fed's...

  • NEW YORK, Sept 19- World stock indexes edged higher and the U.S. dollar weakened on Monday on expectations the U.S. In Japan, policymakers could well go in the opposite direction by easing policy, though conflicting reports on what the central bank might do have stoked uncertainty. "The market is resigned to believing that not going to raise rates this week," said...

  • *Sarepta soars after FDA approves muscle drug. Sept 19- Wall Street edged higher on Monday, with gains in big bank stocks offsetting a drag from Apple shares, as investors braced for the outcome of the Federal Reserve meeting later this week. The Fed is expected to leave interest rates unchanged at the two-day meeting, but investors will assess Chair Janet Yellen's...

  • *Wall Street led higher by financial stocks. NEW YORK, Sept 19- World stock indexes climbed and the U.S. dollar weakened on Monday on expectations the U.S. In Japan, policymakers could well go in the opposite direction by easing policy, though conflicting reports on what the central bank might do have stoked uncertainty.

  • NEW YORK, Sept 19- The Bank of Japan may steal the thunder from the U.S. "The BOJ is important in part because the Japanese have been buying anything abroad that gives them yields," said David Keeble, global head of interest rates strategy at Credit Agricole Corporate& Investment Bank in New York. Last week, the yield on 10- year Japanese government debt rose close to...

  • The drug was the first in the United States to be approved for the devastating disease and Sarepta's stock nearly doubled in value to $56.18 following the decision. Tim Lugo, an analyst with William Blair, estimates the drug will generate global peak annual sales of close to $2 billion. The FDA also granted Sarepta a rare pediatric disease voucher which...

  • SAO PAULO, Sept 19- Latin American stocks and currencies mostly rose on Monday, boosted by rising oil prices and bets the Federal Reserve will strike a cautious tone in its policy statement this week. Oil prices rose 2 percent on Monday after Venezuela hinted that OPEC and major producers could agree to a market support deal, lifting the Colombian peso.

  • New York City Queens view

    Recently, neighborhoods such as Woodside, Sunnyside and Astoria have been the beneficiaries of a large population boom and surging real estate.

  • LONDON, Sept 19- Germany's benchmark 10- year bond yield held above zero percent on Monday, with the market's focus firmly on central bank meetings in Washington and Tokyo this week. What the BOJ says and does could have ramifications for euro zone bond markets, analysts said, since the European Central Bank is in the midst of its own QE program and there are...

  • *Sarepta soars after FDA approve muscle drug. Sept 19- Wall Street was higher on Monday, lifted by financial and energy stocks, a day before the Federal Reserve meets to discuss interest rates. The central bank is expected to leave rates unchanged at the two-day meeting, but investors will assess Fed Chair Janet Yellen's speech on Wednesday for clues on the timing...

  • *BOJ, Fed scheduled to meet Sept 20-21. NEW YORK, Sept 19- The U.S. dollar fell from Friday's more than two-week high against a basket of major currencies on Monday on expectations that any Bank of Japan action this week would not weaken the yen and the Federal Reserve would refrain from raising rates. A growing belief that the BOJ will stop short of the dramatic action...

  • The FDA said Sarepta was required to conduct a trial to confirm the drug's effectiveness, without which the regulator may withdraw approval. Until now there have been no FDA- approved drugs for DMD, and pressure has been increasing on the regulator to swiftly approve treatments. The FDA issued a scathing review of the drug in April, suggesting its perceived...

  • Sept 19- Sarepta Therapeutics Inc's Duchenne muscular dystrophy drug won approval from the U.S. Food and Drug Administration on Monday, capping months of regulatory uncertainty and pressure from parents and patient advocates to endorse it. The FDA said on Monday that Sarepta was required to conduct a trial to confirm the drug's effectiveness, without which...

  • Sept 19- U.S. stocks were higher on Monday as oil prices bounced back from multi-week lows and investors expected the Federal Reserve to leave interest rates unchanged at its meeting this week. Oil prices rose about 1 percent after Venezuela said OPEC and non- OPEC producers were close to a deal to stabilize an oversupplied market. Fed Chair Janet Yellen is...

  • Sept 19- The U.S. Food and Drug Administration approved Bayer AG's hormonal contraceptive device, Kyleena, to prevent pregnancy for up to five years, the German company said on Monday. LARCs, including IUDs and implants, are more effective than other contraceptives such as pills and patches, and are nearly as effective as sterilization, according to the U.S....

  • Sept 19- Wall Street looked set to open higher on Monday as oil prices bounced back from multi-week lows and investors expected the Federal Reserve to hold steady on interest rates at its meeting this week. Oil prices rose about 1.3 percent after Venezuela said OPEC and non- OPEC producers were close to a deal to stabilize an oversupplied market.